BOK Financial Private Wealth’s Biogen BIIB Stock Holding History

BOK Financial Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.54K	Buy	+21	New	+$4.02K	﹤0.01%	511

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOK Financial Private Wealth's BIIB Position: Q2 2026 in Review

BOK Financial Private Wealth opened a new position in Biogen (BIIB) in Q2 2026: 21 shares worth $4.54K. The stake represents ﹤0.01% of the portfolio and ranks #511 among its holdings.

1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

BOK Financial Private Wealth held 21 shares of Biogen worth $4.54K as of Q2 2026.
Biogen was a new BOK Financial Private Wealth position in Q2 2026.
Biogen made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q2 2026, its #511 holding.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.